Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-12-30

FDA Approved: REMERONSOLTAB — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for REMERON SolTab (mirtazapine) from Organon LLC, resulting in a labeling change.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REMERONSOLTAB (Mirtazapine)

Snippet

SUPPL AP for REMERONSOLTAB (MIRTAZAPINE)